Zheng Ze, Bo Xiaowen, He Songyuan, Peng Hongyu, Wang Ping, Cheng Shujuan, Fan Qian, Liu Jinghua
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, 100069 Beijing, China.
Rev Cardiovasc Med. 2025 Apr 18;26(4):26991. doi: 10.31083/RCM26991. eCollection 2025 Apr.
Chronic total occlusion (CTO) is a complex and difficult type of coronary lesion for which elective secondary intervention after subintimal plaque modification (SPM) can improve the success rate. This study sought to determine the most appropriate timing for secondary interval interventions to maximize the benefit to the patient.
This study retrospectively included patients who failed their first CTO percutaneous coronary intervention (PCI) at Beijing Anzhen Hospital Department of Cardiology from January 2019 to December 2022. We reviewed the clinical characteristics, procedural features, and outcomes of patients who underwent SPM and returned to our institution for a second CTO-PCI.
Of the 2847 patients who visited our institution between January 2019 and December 2022, 528 underwent SPM and returned to our institution on an elective basis for a secondary procedure. Of these, 236 procedures were performed within 30 days (Group I), and 292 were performed between 30 and 90 days (Group II). After the intervention, the occluded segment was successfully opened in 170 (72.0%) Group I and 248 (84.9%) Group II participants. When analyzing the factors for operational failure, we found that different intervals, diabetes mellitus, hyperlipidemia, and a history of previous PCI or percutaneous coronary angioplasty (PTCA) were the reasons for the secondary intervention failure. When analyzing the safety of the procedure, we found that pericardial effusion was the most common complication after the procedure, with an incidence of 7.4%. There was no notable variation in the incidence of pericardial effusion between the two groups, 8.9% vs. 6.2% ( = 0.232).
Higher success rates were observed when secondary procedures were performed between 30 and 90 days instead of within 30 days after the initial CTO-PCI SPM, with no significant difference in safety noted between the two groups.
慢性完全闭塞(CTO)是一种复杂且棘手的冠状动脉病变类型,对于此类病变,在进行内膜下斑块修饰(SPM)后进行择期二次干预可提高成功率。本研究旨在确定二次间隔干预的最合适时机,以使患者获益最大化。
本研究回顾性纳入了2019年1月至2022年12月在北京安贞医院心内科首次CTO经皮冠状动脉介入治疗(PCI)失败的患者。我们回顾了接受SPM并返回我院进行第二次CTO-PCI的患者的临床特征、手术特点和结局。
在2019年1月至2022年12月期间来我院就诊的2847例患者中,528例接受了SPM并择期返回我院进行二次手术。其中,236例手术在30天内进行(第一组),292例在30至90天之间进行(第二组)。干预后,第一组170例(72.0%)和第二组248例(84.9%)参与者的闭塞节段成功开通。在分析手术失败的因素时,我们发现不同的间隔时间、糖尿病、高脂血症以及既往PCI或经皮冠状动脉腔内血管成形术(PTCA)史是二次干预失败的原因。在分析手术安全性时,我们发现心包积液是术后最常见的并发症,发生率为7.4%。两组心包积液的发生率无显著差异,分别为8.9%和6.2%(P = 0.232)。
在初次CTO-PCI SPM后30至90天进行二次手术的成功率高于30天内进行二次手术,且两组在安全性方面无显著差异。